Medpace Holdings (NASDAQ: MEDP) reported Q3 EPS of $4.84, $0.40 better than the analyst estimate of $4.44. Revenue for the quarter came in at $716 million versus the consensus estimate of $714.47 million.

GUIDANCE:

Medpace Holdings sees FY2026 EPS of $17.97-$18.32, versus the consensus of $17.72. Medpace Holdings sees FY2026 revenue of $2.835-2.855 billion, versus the consensus of $2.852 billion.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.